Translational Research Laboratory on Aging and Pulmonary Fibrosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico.
Interstitial Lung Disease and Rheumatology Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico.
Eur Respir J. 2020 Aug 13;56(2). doi: 10.1183/13993003.01380-2019. Print 2020 Aug.
Hypersensitivity pneumonitis is an immune-mediated disease triggered by exposure to organic particles in susceptible individuals. It has been reported that a subgroup of patients with hypersensitivity pneumonitis develops autoantibodies with or without clinical manifestations of autoimmune disease. However, the mechanisms involved in this process and the effect of the autoantibodies on clinical course in hypersensitivity pneumonitis is unknown. We evaluated the association between human leukocyte antigen (HLA) class II alleles and hypersensitivity pneumonitis patients with and without autoantibodies.
170 hypersensitivity pneumonitis patients were included. We analysed the presence of antinuclear antibodies, rheumatoid factor, anti-SSA/Ro, anti-SSB/La and anti-CCP at the time of diagnosis. In addition, in a subset of patients we evaluated anti-Scl-70, anti-neutrophil cytoplasmic antibody, and anti-DNA. HLA typing was performed using PCR sequence-specific primers in a high-resolution modality, including and loci. Statistical analysis was performed employing Epi-Info v7 and SPSS v20.
60 hypersensitivity pneumonitis patients showed sera autoantibodies (HPAbs), and 110 hypersensitivity pneumonitis patients did not (HPAbs). The frequency of the allele was remarkably increased in the HPAbs group (10.8% 0.45%; OR 30.14, 95% CI 3.83-237.1; p=1.65×10 after Bonferroni's correction). Likewise, we found that the haplotype , which is part of the 8.1 ancestral haplotype, a major genetic determinant of autoimmune diseases, confers significant risk to develop autoantibodies (OR 19.23, 95% CI 2.37-155.9; p=0.0088 after Bonferroni's correction). In addition, the allele was associated with higher mortality in patients with hypersensitivity pneumonitis (adjusted OR 5.9, 95% CI 1.05-33.05; p=0.043).
A subset of hypersensitivity pneumonitis patients presents circulating autoantibodies and higher mortality that are associated with some alleles of 8.1 ancestral haplotype.
过敏性肺炎是一种由易感个体暴露于有机颗粒而引发的免疫介导性疾病。据报道,一小部分过敏性肺炎患者会产生自身抗体,无论是否伴有自身免疫性疾病的临床表现。然而,目前尚不清楚这一过程涉及的机制以及自身抗体对过敏性肺炎临床病程的影响。我们评估了人类白细胞抗原(HLA)II 类等位基因与伴有和不伴有自身抗体的过敏性肺炎患者之间的关联。
纳入 170 例过敏性肺炎患者。我们分析了患者在诊断时是否存在抗核抗体、类风湿因子、抗 SSA/Ro、抗 SSB/La 和抗 CCP。此外,在一部分患者中,我们还评估了抗 Scl-70、抗中性粒细胞胞质抗体和抗 DNA。采用 PCR 序列特异性引物在高分辨率模式下进行 HLA 分型,包括 和 基因座。统计分析采用 Epi-Info v7 和 SPSS v20 进行。
60 例过敏性肺炎患者出现血清自身抗体(HPAbs),110 例患者未出现(HPAbs)。在 HPAbs 组,等位基因 的频率显著增加(10.8% vs. 0.45%;OR 30.14,95%CI 3.83-237.1;p=1.65×10,经 Bonferroni 校正)。同样,我们发现 8.1 祖先单倍型的一部分 单倍型,这是自身免疫性疾病的主要遗传决定因素,显著增加了发生自身抗体的风险(OR 19.23,95%CI 2.37-155.9;p=0.0088,经 Bonferroni 校正)。此外,在过敏性肺炎患者中,等位基因 与更高的死亡率相关(校正 OR 5.9,95%CI 1.05-33.05;p=0.043)。
一小部分过敏性肺炎患者存在循环自身抗体和更高的死亡率,这与 8.1 祖先单倍型的某些等位基因相关。